- ImageneBio, Inc. Press Release (IS): FY GAAP EPS of -$9.64.
- Cash Position: As of December 31, 2025, the Company had cash, cash equivalents and marketable securities of $135.3 million compared to $12.1 million as of December 31, 2024.
-
Net Loss: Net loss for the three months ended December 31, 2025 was $6.9 million compared to $4.8 million for the same period in 2024. The enhance of $2.1 million was due to additional post-Merger operating expenses and related transaction costs.
ImageneBio, Inc. GAAP EPS of -$9.64
Featured in:
Stock Market